These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution. Tsung AJ; Prabhu SS; Lei X; Chern JJ; Benjamin Bekele N; Shonka NA J Neurooncol; 2011 Dec; 105(3):555-62. PubMed ID: 21643841 [TBL] [Abstract][Full Text] [Related]
4. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis. Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082 [TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study. Zhang M; Li R; Pollom EL; Amini A; Dandapani S; Li G J Clin Neurosci; 2020 Dec; 82(Pt A):122-127. PubMed ID: 33317719 [TBL] [Abstract][Full Text] [Related]
6. Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection. Carroll KT; Bryant AK; Hirshman B; Alattar AA; Joshi R; Gabel B; Carter BS; Harismendy O; Vaida F; Chen CC World Neurosurg; 2018 Mar; 111():e790-e798. PubMed ID: 29309983 [TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter? Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326 [TBL] [Abstract][Full Text] [Related]
8. Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma. Picart T; Meyronet D; Pallud J; Dumot C; Metellus P; Zouaoui S; Berhouma M; Ducray F; Bauchet L; Guyotat J; ; J Cancer Res Clin Oncol; 2021 Jun; 147(6):1843-1856. PubMed ID: 33399987 [TBL] [Abstract][Full Text] [Related]
9. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis. Wen J; Chen W; Zhu Y; Zhang P BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109 [TBL] [Abstract][Full Text] [Related]
10. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis. Perkins SM; Mitra N; Fei W; Shinohara ET J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450 [TBL] [Abstract][Full Text] [Related]
11. The impact of surgery on survival after progression of glioblastoma: A retrospective cohort analysis of a contemporary patient population. Sastry RA; Shankar GM; Gerstner ER; Curry WT J Clin Neurosci; 2018 Jul; 53():41-47. PubMed ID: 29680441 [TBL] [Abstract][Full Text] [Related]
12. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base. Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053 [TBL] [Abstract][Full Text] [Related]
13. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121 [TBL] [Abstract][Full Text] [Related]
14. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study. Lam S; Lin Y; Zinn P; Su J; Pan IW J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237 [TBL] [Abstract][Full Text] [Related]
15. Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database. Bartek J; Alattar AA; Dhawan S; Ma J; Koga T; Nakaji P; Dusenbery KE; Chen CC J Neurooncol; 2019 Oct; 145(1):75-83. PubMed ID: 31471790 [TBL] [Abstract][Full Text] [Related]
16. The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. Sonabend AM; Zacharia BE; Goldstein H; Bruce SS; Hershman D; Neugut AI; Bruce JN J Neurosurg; 2014 Feb; 120(2):300-8. PubMed ID: 24286142 [TBL] [Abstract][Full Text] [Related]
17. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients. Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115 [TBL] [Abstract][Full Text] [Related]
18. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. Zinn PO; Colen RR; Kasper EM; Burkhardt JK Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774 [TBL] [Abstract][Full Text] [Related]
19. Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas. Bagley JH; Babu R; Friedman AH; Adamson C Neurosurg Focus; 2013 Feb; 34(2):E7. PubMed ID: 23373452 [TBL] [Abstract][Full Text] [Related]
20. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. Noorbakhsh A; Tang JA; Marcus LP; McCutcheon B; Gonda DD; Schallhorn CS; Talamini MA; Chang DC; Carter BS; Chen CC J Neurosurg; 2014 Jan; 120(1):31-9. PubMed ID: 24205904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]